2025 HCPCS Code J7513
Daclizumab, parenteral, 25 mg
| Short Description | Daclizumab, parenteral |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 1999 |
| HCPCS Action Effective Date | January 01, 2018 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J1952 - Leuprolide inj, camcevi, 1mg
- J1953 - Levetiracetam injection
- J1954 - Inj leu acet lutr dpt 7.5 mg
- J1955 - Inj levocarnitine per 1 gm
- J1956 - Levofloxacin injection
- J1960 - Levorphanol tartrate inj
- J1961 - Inj lenacapavir (hiv tx) 1mg
- J1980 - Hyoscyamine sulfate inj
- J1990 - Chlordiazepoxide injection
- J2001 - Lidocaine injection
- J2002 - Inj, lidocaine in d5w, 1 mg
- J2003 - Inj, lidocaine hcl, 1 mg
- J2004 - Inj, lidocaine w epinephrine
- J2010 - Lincomycin injection
- J2020 - Linezolid injection
- J2021 - Inj, linezolid (hospira)
- J2060 - Lorazepam injection
- J2062 - Loxapine for inhalation 1 mg
- J2150 - Mannitol injection
- J2151 - Inj, mannitol, 250 mg